AWARD OUTCOME
What happened
Cell Therapy Catapult Limited awarded and signed a direct contract with Repligen B.V for non-GMP Alternating Tangential Flow equipment supporting process development for later GMP manufacturing transfer. The contract includes a one-year equipment warranty and may be followed by an additional one-year service contract.
Published outcomeOne active award and active contract are recorded for Repligen B.V. The contract was signed and started on 29 September 2026.
Market significanceThis is a €254,479 excluding-VAT direct purchase of specialist bioprocess equipment. The buyer cited technical reasons and absence of reasonable alternatives for selecting an ATF system aligned with planned GMP manufacturing.
AWARDED SUPPLIERS AND LOTS
1 supplier record analysed
Repligen B.V
99% confidenceAward 1 · Lots 1 · €254,479 excluding VAT; €305,375 including VAT EUR · Active contract
View supporting evidence
Award 1 names Repligen B.V as supplier. Contract 1 linked to award 1 states values of EUR 254,479 and EUR 305,375 gross.
LIFECYCLE
Award or contract stage
Current record status
99% confidenceActive contract
View supporting evidence
The award and contract are both marked "active" in the supplied contract details notice data.
Award announcement
96% confidence22 July 2026
View supporting evidence
The award record gives award_date as 2026-07-22; release history records a Contract award notice published that day.
Contract signed
99% confidence29 September 2026
View supporting evidence
Contract 1 gives dateSigned as 2026-09-29.
Contract start
99% confidence29 September 2026
View supporting evidence
Contract period startDate is 2026-09-29.
Contract details publication
99% confidence13 October 2026
View supporting evidence
The contract details notice is dated 2026-10-13.
VALUES
Published values explained
Contract value excluding VAT
99% confidence€254,479
View supporting evidence
Contract 1 value.amount is 254479 EUR; the description also states €254,479 excluding VAT.
Contract value including VAT
99% confidence€305,375
View supporting evidence
Contract 1 value.amountGross is 305375 EUR.
Award-record value
98% confidence€288,232
View supporting evidence
The supplied award summary record lists value_amount of 288232 EUR.
TIMELINE
Procurement timeline
Transparency notice
98% confidence15 July 2026
View supporting evidence
Release history records transparency notice 066780-2026 on 2026-07-15.
Award notice
99% confidence22 July 2026
View supporting evidence
Release history records contract award notice 069001-2026 on 2026-07-22.
Contract term
99% confidence29 September 2026 to 23 October 2027
View supporting evidence
Contract 1 period runs from 2026-09-29 to 2027-10-23.
SCOPE
What was awarded
Requirement
99% confidenceNon-GMP Alternating Tangential Flow equipment for process development activities intended for later transfer to GMP manufacturing.
View supporting evidence
Tender description.
Procurement categories
98% confidenceGoods, with associated services
View supporting evidence
Award 1 lists goods as the main procurement category and services as an additional category.
Classifications
99% confidenceBiomedical equipment; repair and maintenance services of medical and precision equipment
View supporting evidence
Award item classifications use CPV 38434540 and 50400000.
Warranty and service option
99% confidenceOne-year equipment warranty; option for an additional one-year service contract.
View supporting evidence
Tender description.
PROCEDURE
Procedure and competition
Procedure
99% confidenceDirect award
View supporting evidence
Tender procurementMethod is "direct" and procurementMethodDetails is "Direct award".
Stated direct-award rationale
99% confidenceThe buyer cited technical reasons, stating that only one supplier could meet the requirement and that no reasonable alternatives were available.
View supporting evidence
Procurement-method rationale cites Schedule 5, paragraph 6 of the Procurement Act 2023.
Technical rationale stated by buyer
98% confidenceThe buyer stated that Repligen was the only supplier of GMP perfusion equipment operating with ATF, and that the corresponding smaller-scale laboratory system was required to support the intended GMP process.
View supporting evidence
Procurement-method rationale.
Competition information
99% confidenceBid count and evaluation information not supplied in the published notice.
View supporting evidence
No bid, score, or evaluation fields are provided.
CONTRACT TERMS
Published contract terms
Signed contract period
99% confidence29 September 2026 to 23 October 2027
View supporting evidence
Contract 1 period and dateSigned fields.
KPIs
99% confidenceNo agreed KPIs
View supporting evidence
The contract states that KPIs were not established because this was a one-off purchase and KPIs were not considered appropriate.
Threshold status
99% confidenceAbove threshold
View supporting evidence
Contract 1 is marked aboveThreshold: true.
COMMERCIAL VIEW
Commercial observations
Commercial structure
98% confidenceThe published record describes a one-off equipment purchase with warranty, rather than a continuous service arrangement.
View supporting evidence
Tender description and the no-agreed-metrics rationale.
Supplier-selection context
98% confidenceThe buyer's published rationale links the laboratory equipment choice to compatibility with its planned Repligen ATF GMP manufacturing setup.
View supporting evidence
Procurement-method rationale.
DATA QUALITY
Gaps and source limitations
Value discrepancy
99% confidenceThe award summary gives €288,232, while the signed contract data gives €254,479 excluding VAT and €305,375 including VAT. The source does not explain the €288,232 figure.
View supporting evidence
Supplied award record and contract value fields.
Lot detail
99% confidenceLot 1 is identified but has no published title, description, or separate lot value.
View supporting evidence
Lot record contains no title, description, or value.
Information not supplied in the published notice
99% confidenceTender deadline, bid count, evaluation scores, detailed pricing, and an award decision date are not provided.
View supporting evidence
Relevant fields are absent or null in the supplied data.
SOURCE DATA LIMITATIONS
Information not supplied in the published notice
- The published source contains conflicting value figures: €288,232 in the award summary, versus €254,479 excluding VAT and €305,375 including VAT in contract data; no explanation is supplied.
- Lot 1 has no published title, description, or allocated value.
- Information on bids, evaluation, pricing breakdown, tender timetable and award decision date is not supplied.
- The possible additional one-year service contract is an option only; the source does not confirm that it has been entered into.
MARKET THEMES
Relevant award themes
Cell Therapy CatapultRepligen B.VATF equipmentAlternating Tangential Flowbioprocess equipmentdirect awardGMP manufacturing
COMMON QUESTIONS
About this award
Who won the ATF equipment contract?
Repligen B.V is named as supplier for award 1.
What is the contract value?
The contract data states €254,479 excluding VAT and €305,375 including VAT. A separate award-summary value of €288,232 is also published without explanation.
Was the contract signed?
Yes. The contract record states it was signed on 29 September 2026.
Why was a direct award used?
The buyer cited technical reasons and stated that no reasonable alternative supplier could meet the requirement.
ProcuraAxis award analysis supplements, but does not replace, the official award notice, contract data or procurement documents. “Awarded” does not by itself prove that a contract has been signed.